Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia

• Marketa Zaliova,
• Eliska Potuckova,
• Julius Lukes,
• Lucie Winkowska,
• Julia Starkova,
• Iveta Janotova,
• Lucie Sramkova,
• Jan Stary,
• Jan Zuna,
• Martin Stanulla,
• Martin Zimmermann,
• Beat Bornhauser,
• Jean-Pierre Bourquin,
• Cornelia Eckert,
• Gunnar Cario,
• Jan Trka

Affiliations

Marketa Zaliova

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;

Eliska Potuckova

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;

Julius Lukes

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;

Lucie Winkowska

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;

Julia Starkova

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;

Iveta Janotova

University Hospital Motol, Prague, Czech Republic;

Lucie Sramkova

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;

Jan Stary

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;

Jan Zuna

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;

Martin Stanulla

Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany;

Martin Zimmermann

Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany;

Beat Bornhauser

Division of Pediatric Oncology, University Children's Hospital, Zurich, Switzerland;

Jean-Pierre Bourquin

Division of Pediatric Oncology, University Children's Hospital, Zurich, Switzerland;

Cornelia Eckert

German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany;

Gunnar Cario

Department of Pediatrics, University Medical Center Schleswig-Holstein, Kiel, Germany

Jan Trka

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;